Business
mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
The mRNA CDMO market is driven by growing demand for mRNA therapeutics in oncology and rare diseases, pushing companies to outsource to CDMOs for scalability. Challenges include a lack of skilled personnel and capacity. Trends favor automated production and novel RNA tech. Key CDMOs include Samsung and Lonza. mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "mRNA
About this update from Samsung Electronics Co., Ltd.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The mRNA CDMO market is driven by growing demand for mRNA therapeutics in oncology and rare diseases, pushing companies to outsource to CDMOs for scalability. Challenges include a lack of skilled personnel and capacity. Trends favor automated production and novel RNA tech. Key CDMOs include Samsung and Lonza.","length":310,"tagName":"p"},{"type":"text","content":"mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market","length":72,"tagName":"p"},{"type":"image","alt":"mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market","displaySize":"","headline":null,"caption":"mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/1abbaa32c4e0431db503ef7b9588ee74"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Oih5bqArGahxcNZtOkPSNQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1abbaa32c4e0431db503ef7b9588ee74","width":600,"height":400}}},{"type":"text","content":"Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's offering.The Global mRNA Therapeutics Contract Development and Manufacturing (CDMO) Market is projected to increase from USD 9.99 billion in 2025 to USD 15.83 billion by 2031, expanding at a CAGR of 7.97%. This market consists of specialized organizations offering outsourcing services for the development, formulation, and commercial manufacturing of messenger RNA-based drugs and vaccines. Growth is primarily driven by the widening clinical pipeline for mRN...